[
  {
    "ts": null,
    "headline": "Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3",
    "summary": "Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.",
    "url": "https://finnhub.io/api/news?id=fff456bf8039ffc9ce50ee63a475543af46acb56d8fdd37f20958e829531a616",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761920100,
      "headline": "Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3",
      "id": 137279339,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.",
      "url": "https://finnhub.io/api/news?id=fff456bf8039ffc9ce50ee63a475543af46acb56d8fdd37f20958e829531a616"
    }
  },
  {
    "ts": null,
    "headline": "Countdown to Humana (HUM) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS",
    "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
    "url": "https://finnhub.io/api/news?id=2e964923fba16ec11e78e3d9846f3430b73e786a02ec70d74a8ae64f77aefb0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761916504,
      "headline": "Countdown to Humana (HUM) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS",
      "id": 137279531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
      "url": "https://finnhub.io/api/news?id=2e964923fba16ec11e78e3d9846f3430b73e786a02ec70d74a8ae64f77aefb0e"
    }
  },
  {
    "ts": null,
    "headline": "Humana (NYSE:HUM) Has A Pretty Healthy Balance Sheet",
    "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
    "url": "https://finnhub.io/api/news?id=48614116322c5daf487f34ff72aae8a47737782e7eb36e7dfdb55292486853d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761912027,
      "headline": "Humana (NYSE:HUM) Has A Pretty Healthy Balance Sheet",
      "id": 137279532,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
      "url": "https://finnhub.io/api/news?id=48614116322c5daf487f34ff72aae8a47737782e7eb36e7dfdb55292486853d0"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock for Long-Term Investors and 2 Facing Challenges",
    "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
    "url": "https://finnhub.io/api/news?id=224210fe083db3a522f86afe754fba710f3d81f2f13b911ebcac8f7a5e06c179",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761885531,
      "headline": "1 S&P 500 Stock for Long-Term Investors and 2 Facing Challenges",
      "id": 137275335,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
      "url": "https://finnhub.io/api/news?id=224210fe083db3a522f86afe754fba710f3d81f2f13b911ebcac8f7a5e06c179"
    }
  }
]